基本信息
浏览量:609
职业迁徙
个人简介
Dr. Shepherd's contribution to the development and conduct of clinical trials is recognized internationally. She was the President of the International Association for the Study of Lung Cancer from 2005-2007. She was a member of the US National Institutes of Health Concept Evaluation Panel for Lung Cancer clinical trials. This body of CTEP (the Cancer Treatment Evaluation Program of the US NCI) was responsible for evaluating and approving all multi-center lung cancer clinical research studies submitted by the large US cooperative groups.
Currently, she sits on the Board of Directors of the American Society of Clinical Oncology and the European Organization for Research and Treatment of Cancer. She also Chairs the European Organization for Research and Treatment of Cancer Protocol Review committee. Dr Shepherd has served as Chair of the American Society of Clinical Oncology Membership and Publications Committees.
Dr. Shepherd has been instrumental in the design and conduct of research studies evaluating the new targeted agents and anti-angiogenesis agents in lung cancer. She has also undertaken translational research studies in this field. Most recently she has developed several large international randomized trials for some of the novel anti-cancer agents that are directed against the epidermal growth factor receptor and other molecular targets.
Currently, she sits on the Board of Directors of the American Society of Clinical Oncology and the European Organization for Research and Treatment of Cancer. She also Chairs the European Organization for Research and Treatment of Cancer Protocol Review committee. Dr Shepherd has served as Chair of the American Society of Clinical Oncology Membership and Publications Committees.
Dr. Shepherd has been instrumental in the design and conduct of research studies evaluating the new targeted agents and anti-angiogenesis agents in lung cancer. She has also undertaken translational research studies in this field. Most recently she has developed several large international randomized trials for some of the novel anti-cancer agents that are directed against the epidermal growth factor receptor and other molecular targets.
研究兴趣
论文共 547 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Benjamin Besse, Elvire Pons-Tostivint,Keunchil Park, Sylvia Hartl, Patrick M. Forde,Maximilian J. Hochmair, Mark M. Awad,Michael Thomas, Glenwood Goss,Paul Wheatley-Price,Frances A. Shepherd, Marie Florescu,
Nature Medicineno. 3 (2024): 716-729
Masahiro Tsuboi,Roy S. Herbst, Thomas John,Terufumi Kato, Margarita Majem,Christian Grohé, Jie Wang,Jonathan W. Goldman, Shun Lu,Filippo de Marinis, Frances A. Shepherd,Ki Hyeong Lee,
Targeted Oncologyno. 2 (2024): 1-4
Amin H. Nassar,So Yeon Kim,Jacqueline V. Aredo, Jamie Feng,Frances Shepherd,Chao Xu, David Kaldas,Jhanelle E. Gray,Thomas J. Dilling,Joel W. Neal,Heather A. Wakelee,Yufei Liu,
Journal of Thoracic Oncology (2024)
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (2024)
The Lancet Public Healthno. 9 (2023): e691-e700
Nasser Hanna,Frances A. Shepherd,Frank V. Fossella,Jose R. Pereira,Filippo De Marinis,Joachim von Pawel,Ulrich Gatzemeier,Thomas Chang Yao Tsao,Miklos Pless, Thomas Muller,Hong-Liang Lim, Christopher Desch,
The New England journal of medicineno. 2 (2023): 137-147
Miguel Garcia-Pardo, Kasia Czarnecka-Kujawa,Jennifer H. Law,Alexandra M. Salvarrey,Roxanne Fernandes, Zhen J. Fan,Thomas K. Waddell,Kazuhiro Yasufuku,Geoffrey Liu,Laura L. Donahoe,Andrew Pierre,Lisa W. Le,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn